News | Shivalik Rasayan Limited

The Company is setting up an Agro-Chemical, synthetic Organic Chemicals & Intermediates plant at Dahej-III with an installed capacity of 20100MT.

SRL has successfully submitted CEP for PIRFENIDONE, TEMOZOLOMIDE, BUSULPHAN to EDQM, Europe.

SRL has successfully submitted its first US Drug Master File (DMF) for BORTEZOMIB through ESG gateway to USFDA.

Dr. Vimal Kumar Shrawat-COO of Shilpa Medicare Limited joins as Managing Director Shivalik Rasayan Limited.

Latest corporate update from Shivalik Rasayan Limited.

Shivalik Rasayan Limited has filed a process patent for Temozolomide, reinforcing its commitment to oncology API innovation.